We are solving the greatest challenges in venous access with a novel biomaterial designed to reduce complications such as catheter occlusion & thrombosis events.
Location: United States, Massachusetts, Bedford
Employees: 11-50
Phone: +1 781-538-6594
Total raised: $51.7M
Founded date: 2015
Investors 1
| Date | Name | Website |
| 04.03.2021 | TVM Capita... | tvm-lifesc... |
Funding Rounds 4
| Date | Series | Amount | Investors |
| 31.10.2023 | Series C | $22M | - |
| 03.03.2021 | Series B | $20M | - |
| 26.09.2019 | - | $6M | - |
| 28.08.2017 | - | $3.7M | angelMD |
Mentions in press and media 12
| Date | Title | Description |
| 31.10.2023 | Access Vascular Raises $22M in Series C Financing | Access Vascular, a Billerica, MA-based company addressing the vascular access complications via a biomaterial platform, raised $22M in Series C funding. Backers included a consortium of new and existing investors. The company intends to use... |
| 31.10.2023 | Veins, VEINS! Access Vascular grabs $22M for biocompatible catheter rollout | Access Vascular hopes to take a bite out of the infections and complications that can come with delivering intravenous therapies, which can cost health systems as much as $4.5 billion per year. The company has developed a line of vascular a... |
| 31.10.2023 | Access Vascular Raises $22M Series C Funding | BILLERICA, MA, Access Vascular has raised a Series C round worth $22 million from a consortium of new and existing investors. >> Click here for more funding data on Access Vascular >> To export Access Vascular funding data t... |
| 04.03.2021 | Access Vascular, Inc. Secures $20 Million in Series B Financing | Bedford, MA – 03 March, 2021- Access Vascular, Inc., a company addressing the most common and costly venous access complications, today announced it has closed on a Series B round of financing. TVM Capital Life Science led the round with a... |
| 03.03.2021 | Access Vascular Secures $20M in Series B | BEDFORD, MA, Access Vascular announced it has closed on a Series B round of financing led by TVM Capital Life Science. >> Click here for more funding data on Access Vascular >> To export Access Vascular funding data to PDF a... |
| 03.03.2021 | Access Vascular, Inc. : Secures $20 Million in Series B Financing | Access Vascular, Inc., a company addressing the most common and costly venous access complications, today announced it has closed on a Series B round of financing. TVM Capital Life Science led the round with a $15 million commitment, with e... |
| 26.09.2019 | Access Vascular Raises $6M in Funding | Access Vascular, a Bedford, Mass.-based medical device company developing intravenous devices from novel biomaterials designed to minimize the risk of bloodstream infection, catheter thrombosis, and vein trauma, raised $6M in funding. Backe... |
| 28.08.2017 | Access Vascular Secures $3.7M In Financing | Access Vascular, a Bedford, MA-based medical device company developing innovative venous access devices that eliminate thrombotic risk, raised $3.7m in funding. Backers included individual investors and angelMD, an investment platform and m... |
| 28.08.2017 | Access Vascular Raises $3.7 Million Funding from angelMD | Access Vascular, a medical device company developing innovative venous access devices that eliminate thrombotic risk, today announced $3.7 million in funding from individual investors and angelMD, an investment platform and marketplace conn... |
| 05.08.2017 | angelMD Announces Investment Syndicate for Access Vascular | angelMD announced an investment syndicate with Access Vascular Inc., a company developing innovative venous access devices. Arun Jagannathan, MD and Orrin Ailloni-Charas, MD, MBA, are leading the company’s first syndicate with angelMD. Acce... |
Show more